Ruebenthaler, Johannes, Cecatka, Sasa, Froelich, Matthias Frank, Stechele, Matthias, Marschner, Constantin, Sabel, Bastian Oliver, Bogner, Florian, Schnitzer, Moritz Ludwig, Overhoff, Daniel, Grosse Hokamp, Nils ORCID: 0000-0001-7928-0487, Staehler, Michael ORCID: 0000-0002-4574-6522, Schwarze, Vincent ORCID: 0000-0003-3910-7801 and Clevert, Dirk-Andre (2020). Contrast-Enhanced Ultrasound (CEUS) for Follow-Up of Bosniak 2F Complex Renal Cystic Lesions-A 12-Year Retrospective Study in a Specialized European Center. Cancers, 12 (8). BASEL: MDPI. ISSN 2072-6694

Full text not available from this repository.

Abstract

Bosniak 2F renal cystic lesions feature morphologic characteristics between Bosniak I and III categories, the majority of which remain benign. However, a minor part of Bosniak 2F lesions may progress to malignancy. The purpose of this study was to assess Bosniak 2F cystic lesions during follow-up examinations by CEUS. One-hundred-and-twelve out of 364 patients with Bosniak 2F lesions underwent follow-up CEUS examinations between February 2008 and February 2020. Twelve out of 364 patients underwent renal surgery without follow-up CEUS. The progression rate of Bosniak 2F renal lesions detected by CEUS accounted for 7.1% (8/112 patients) after a mean of 12.9 months. The first follow-up CEUS revealed 75% of progressions (6/8), the remaining 25% (2/8) of progressions were detected during second follow-up CEUS. Underlying clear-cell renal cell carcinoma was histopathologically validated in 5/8 progressive complex cystic renal lesions. Stable sonomorphologic features were observed in 92.1% (104/112 patients). CEUS depicts a promising diagnostic imaging modality in the diagnostic work-up and follow-up of complex renal cystic lesions at higher spatial and temporal resolutions than CT or MRI. Its excellent safety profile, its easy and repeatable accessibility, and low financial costs render CEUS an attractive and powerful alternative imaging tool for monitoring complex renal cystic lesions.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Ruebenthaler, JohannesUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cecatka, SasaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Froelich, Matthias FrankUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stechele, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Marschner, ConstantinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sabel, Bastian OliverUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bogner, FlorianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schnitzer, Moritz LudwigUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Overhoff, DanielUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grosse Hokamp, NilsUNSPECIFIEDorcid.org/0000-0001-7928-0487UNSPECIFIED
Staehler, MichaelUNSPECIFIEDorcid.org/0000-0002-4574-6522UNSPECIFIED
Schwarze, VincentUNSPECIFIEDorcid.org/0000-0003-3910-7801UNSPECIFIED
Clevert, Dirk-AndreUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-324240
DOI: 10.3390/cancers12082170
Journal or Publication Title: Cancers
Volume: 12
Number: 8
Date: 2020
Publisher: MDPI
Place of Publication: BASEL
ISSN: 2072-6694
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
COMPUTED-TOMOGRAPHY; CELL CARCINOMA; DIAGNOSTIC PERFORMANCE; CATEGORY IIF; CLASSIFICATION; MASSES; CT; MANAGEMENT; MRI; RADIATIONMultiple languages
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/32424

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item